Home Marina Biotech and Mirna Therapeutics Amend License Agreement for the ...
 

Keywords :   


Marina Biotech and Mirna Therapeutics Amend License Agreement for the ...

2014-01-03 03:24:21| Biotech - Topix.net

Under terms of the amendment, Mirna paid certain pre-payments to Marina Biotech and now has additional rights to its lead program, MRX34, currently in Phase 1 clinical development for patients with unresectable primary liver cancer or metastatic cancer with liver involvement.

Tags: the agreement license marina

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
30.11 C46
30.11 2014
30.11
30.11CD ! !vol.514
30.11D D
30.11AMAKUNIHobb Japan
30.11 SP
30.11MIZUNO
More »